2026 Global: Neurology Devices Market -Competitive Review (2032) report
Description
The 2026 Global: Neurology Devices Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
The neurology devices market is dominated by ten major companies that collectively shape the industry landscape through innovation, extensive product portfolios, and global reach. Integra LifeSciences, headquartered in Princeton, New Jersey, USA, is a leading global medical technology company dedicated to regenerative medicine and neurosurgical solutions, offering tools for brain and spinal procedures including cranial access kits, dural repair products, and monitoring systems. B. Braun SE, based in Melsungen, Germany, stands as one of the world's largest medical and pharmaceutical device companies with a portfolio spanning over 5,000 healthcare products, specializing in neurocritical care and neurosurgical equipment including surgical instruments, infusion therapy devices, and intracranial pressure monitoring products. Medtronic plc, headquartered in Dublin, Ireland, operates as a global leader in medical technology with an extensive neurology device portfolio featuring deep brain stimulation systems, neurovascular products, and spinal cord stimulators addressing chronic neurological conditions such as Parkinson's disease and epilepsy. Abbott Laboratories, based in Abbott Park, Illinois, USA, operates across seven industrial divisions and received FDA approval in October 2023 for its NeuroSphere® Vertera™ deep brain stimulation system for treatment-resistant depression.
Boston Scientific Corporation maintains a prominent position in the neurology devices market with comprehensive neuromodulation and neurovascular product offerings serving North American and global markets. Stryker Corporation, headquartered in Kalamazoo, Michigan, USA, contributes significantly to the neurosurgical and neuromodulation segments with innovative solutions for neurological applications. Johnson & Johnson, located in New Brunswick, New Jersey, USA, operates as the largest independent biotech firm by market capitalization with total revenue of $82.06 billion USD and maintains extensive presence across 250 subsidiary companies in 60 countries. Natus Medical Inc., based in Middleton, Wisconsin, USA, delivers comprehensive neurodiagnostic solutions including EEG, sleep diagnostics, and intraoperative monitoring systems. Nihon Kohden Corporation is renowned for high-precision EEG and neuromonitoring devices widely adopted in hospitals and neurology clinics worldwide, with operations spanning multiple global markets.
LivaNova PLC completes the roster of major players, contributing specialized neuromodulation and cardiac solutions to the global neurology devices landscape. These ten companies collectively demonstrate the market's concentration among established multinational enterprises maintaining their leadership through extensive product portfolios, strong geographical presence, and significant research and development investments. North America remains the dominant region for neurology devices, generating the highest demand during the forecast period due to strategic government initiatives, advanced healthcare infrastructure, significant CNS research presence, and continuous product innovations with frequent FDA approvals. The competitive landscape reflects intense competition among these key players, with the market characterized as a mix of established multinational companies focusing on multiple neurological applications including neuromodulation, neurovascular interventions, neurosurgical instruments, and diagnostic monitoring systems.
The neurology devices market is dominated by ten major companies that collectively shape the industry landscape through innovation, extensive product portfolios, and global reach. Integra LifeSciences, headquartered in Princeton, New Jersey, USA, is a leading global medical technology company dedicated to regenerative medicine and neurosurgical solutions, offering tools for brain and spinal procedures including cranial access kits, dural repair products, and monitoring systems. B. Braun SE, based in Melsungen, Germany, stands as one of the world's largest medical and pharmaceutical device companies with a portfolio spanning over 5,000 healthcare products, specializing in neurocritical care and neurosurgical equipment including surgical instruments, infusion therapy devices, and intracranial pressure monitoring products. Medtronic plc, headquartered in Dublin, Ireland, operates as a global leader in medical technology with an extensive neurology device portfolio featuring deep brain stimulation systems, neurovascular products, and spinal cord stimulators addressing chronic neurological conditions such as Parkinson's disease and epilepsy. Abbott Laboratories, based in Abbott Park, Illinois, USA, operates across seven industrial divisions and received FDA approval in October 2023 for its NeuroSphere® Vertera™ deep brain stimulation system for treatment-resistant depression.
Boston Scientific Corporation maintains a prominent position in the neurology devices market with comprehensive neuromodulation and neurovascular product offerings serving North American and global markets. Stryker Corporation, headquartered in Kalamazoo, Michigan, USA, contributes significantly to the neurosurgical and neuromodulation segments with innovative solutions for neurological applications. Johnson & Johnson, located in New Brunswick, New Jersey, USA, operates as the largest independent biotech firm by market capitalization with total revenue of $82.06 billion USD and maintains extensive presence across 250 subsidiary companies in 60 countries. Natus Medical Inc., based in Middleton, Wisconsin, USA, delivers comprehensive neurodiagnostic solutions including EEG, sleep diagnostics, and intraoperative monitoring systems. Nihon Kohden Corporation is renowned for high-precision EEG and neuromonitoring devices widely adopted in hospitals and neurology clinics worldwide, with operations spanning multiple global markets.
LivaNova PLC completes the roster of major players, contributing specialized neuromodulation and cardiac solutions to the global neurology devices landscape. These ten companies collectively demonstrate the market's concentration among established multinational enterprises maintaining their leadership through extensive product portfolios, strong geographical presence, and significant research and development investments. North America remains the dominant region for neurology devices, generating the highest demand during the forecast period due to strategic government initiatives, advanced healthcare infrastructure, significant CNS research presence, and continuous product innovations with frequent FDA approvals. The competitive landscape reflects intense competition among these key players, with the market characterized as a mix of established multinational companies focusing on multiple neurological applications including neuromodulation, neurovascular interventions, neurosurgical instruments, and diagnostic monitoring systems.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
